Transforming the linkage to care
MagIA diagnostics Point-of-Care screening will transform the way patients are linked to care.
Multiplexed
Up to 4 parameters at once
Broad screening campaigns
Fast
Results given in 20 minutes
Just in time for a consultation
Small sample
Just 50 µl of capillary blood
Easy to use and non-invasive
portable
A system weight below 3 kg
Get it done wherever needed
Syndromic testing
MagIA diagnostics offers a new approach against infectious diseases by using a single test detecting all the microorganisms most commonly responsible for a co-infection. The portable system allows for up to 8 related markers to be screened in parallel.
Our syndromic testing approach will offer many advantages for patients and health care professionals, including more analyses in less time and effort and delocalised diagnostics, resulting in a better linkage to care.
One system – endless testing
MagIA diagnostics will offer a large panel of syndromic testing panels – all based on the same analyzer.
Cartridges
Our single-use cartridges are the key to the system’s flexibility and simplicity. Each cartridge covers a unique panel of related markers while remaining compatible to our analyzer. Simply introduce your sample and analyze up to two cartridges simultaneously!
Analyzer
Disrupting today’s blood-testing standards, the MagIA diagnostic Analyzer brings laboratory quality testing to the Point of Care. The portable system works in an easy and straightforward way, so it can be handled by medical or non-medical professionals.
Latest News
The latest updates from MagIA diagnostics.
Interview de Paul Kauffmann sur France Bleue Isère
La Nouvelle éco en Isère : MagIA diagnostics, spécialiste du dépistage rapide, lance sa phase industrielle (francebleu.fr)
Grand Défi Bioproduction
MagIA diagnostics a été retenue par le Grand Défi Bioproduction (Secrétariat général pour l'investissement) dans le cadre d’un appel à projet. Le projet porte sur l’adaptation de sa technologie pour en faire un outil de mesure de biomédicaments (anticorps...
Analyses de patients en condition réelles
MagIA travaille avec le CIC/ CHUGA pour la validation préliminaire de notre démonstrateur de diagnostic in vitro destiné au dépistage de l’hépatite B. Un de nos lecteurs sert en ce moment même à l’analyse de patients en conditions réelles. Sur cette...
Visit us
MagIA diagnostics, based in the south of Grenoble, is a spin-off from Grenoble INP with multiple patent protections for its disruptive Point-of-Care technology.
The technology is the achievement of ten years of R&D in the Grenoble research community.
MagIA diagnostics SAS
15 rue Maréchal Leclerc
38130 Echirolles
France